The problem of toxoplasmosis in outpatient practice. Part I. Toxoplasmosis in immunocompetent patients

Cover Page

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract

Acute toxoplasmosis in immunocompetent persons most often proceeds subclinically and ends with the formation of latent toxoplasmosis, which does not require therapy and observation. The presence of clinical signs of a long-term disease forces an extensive diagnostic search to exclude/confirm chronic toxoplasmosis. In the treatment of toxoplasmosis in persons without immunodeficiency, repeated courses of antiprotozoal drugs are used, which do not guarantee clinical recovery and the absence of relapses. Perinatal aspects of toxoplasmosis will be discussed in a future publication.

About the authors

Valerii V. Vasiliev

North-Western State Medical University named after I.I. Mechnikov; Pediatric Research and Clinical Center for Infectious Diseases of federal medical and biological agency

Author for correspondence.
Email: vcubed@ya.ru
ORCID iD: 0000-0003-2579-2799
SPIN-code: 5644-9877
Scopus Author ID: 57192667926
ResearcherId: HPG-3481-2023

MD, Dr. Sci. (Med.), Professor

Russian Federation, 41 Kirochnaya St., Saint Petersburg, 191015; Saint Petersburg

Nikolai I. Kuznetsov

North-Western State Medical University named after I.I. Mechnikov

Email: meri-kuz-48@mail.ru
ORCID iD: 0000-0001-5378-3860
SPIN-code: 2558-9273

MD, Dr. Sci. (Med.), Professor

Russian Federation, 41 Kirochnaya St., Saint Petersburg, 191015

Galina Yu. Startseva

North-Western State Medical University named after I.I. Mechnikov

Email: star661@rambler.ru
ORCID iD: 0000-0002-3660-2666
SPIN-code: 8392-2950
Scopus Author ID: 442573

MD, Cand. Sci. (Med.), Assistant Professor

Russian Federation, 41 Kirochnaya St., Saint Petersburg, 191015

References

  1. De Lima Bessa G, de Almeida Vitor RW, Dos Santos Martins-Duarte E. Toxoplasma gondii in South America: a differentiated pattern of spread, population structure and clinical manifestations. Parasitol Res. 2021;120(9):3065–3076. doi: 10.1007/s00436-021-07282-w
  2. Weiss LM, Dubey JP. Toxoplasmosis: A history of clinical observations. Int J Parasitol. 2009;39(8):895–901. doi: 10.1016/j.ijpara.2009.02.004
  3. Ybañez RHD, Ybañez AP, Nishikawa Y. Review on the current trends of toxoplasmosis serodiagnosis in humans. Front Cell Infect Microbiol. 2020;10:204. doi: 10.3389/fcimb.2020.00204
  4. Hajissa K, Zakaria R, Suppian R, Mohamed Z. Design and evaluation of a recombinant multi-epitope antigen for serodiagnosis of Toxoplasma gondii infection in humans. Parasit Vectors. 2015;8:315. doi: 10.1186/s13071-015-0932-0
  5. Robert MG, Brenier-Pinchart MP, Garnaud C, et al. Molecular diagnosis of toxoplasmosis: recent advances and a look to the future. Expert Rev Anti Infect Ther. 2021;19(12):1529–1542. doi: 10.1080/14787210.2021.1941867
  6. Hurt C, Tammaro D. Diagnostic evaluation of mononucleosis-like illnesses. Am J Med. 2007;120(10):911.e1–8. doi: 10.1016/j.amjmed.2006.12.011
  7. Liu KY, Chao HM, Lu YJ, et al. Cytomegalovirus proctitis in non-human immunodeficiency virus infected patients: A case report and literature review. J Microbiol Immunol Infect. 2022;55(1):154–160. doi: 10.1016/j.jmii.2021.10.002
  8. Beder D, Esenkaya Taşbent F. General features and laboratory diagnosis of toxoplasma gondii infection. Turkiye Parazitol Derg. 2020;44(2):94–101. doi: 10.4274/tpd.galenos.2020.6634
  9. Brenier-Pinchart MP, Filisetti D, Cassaing S, et al. Molecular diagnosis of toxoplasmosis: Multicenter evaluation of the toxoplasma realcycler universal PCR assay on 168 characterized human samples. J Mol Diagn. 2022;24(6):687–696. doi: 10.1016/j.jmoldx.2022.03.009
  10. Neves ES, Espíndola OM, Curi A, et al. PCR-based diagnosis is not always useful in the acute acquired toxoplasmosis in immunocompetent individuals. Parasitol Res. 2021;120(2):763–767. doi: 10.1007/s00436-020-07022-6
  11. Lobzin YuV, Vasiliev VV. Priobretennii toxoplazmoz: kriterii diagnostoki i printsipy terapii. Rossiiskii meditsinskii zhurnal. 2001;2:43–45. (In Russ.)
  12. Fabiani S, Caroselli C, Menchini M, et al. Ocular toxoplasmosis, an overview focusing on clinical aspects. Acta Trop. 2022;225:106180. doi: 10.1016/j.actatropica.2021.106180
  13. Patel NS, Vavvas DG. Ocular toxoplasmosis: a review of current literature. Int Ophthalmol Clin. 2022;62(2):231–250. doi: 10.1097/IIO.0000000000000419
  14. Kalogeropoulos D, Sakkas H, Mohammed B, et al. Ocular toxoplasmosis: a review of the current diagnostic and therapeutic approaches. Int Ophthalmol. 2022;42(1):295–321. doi: 10.1007/s10792-021-01994-9
  15. Feliciano-Alfonso JE, Muñoz-Ortiz J, Marín-Noriega MA, et al. Safety and efficacy of different antibiotic regimens in patients with ocular toxoplasmosis: systematic review and meta-analysis. Syst Rev. 2021;10(1):206. doi: 10.1186/s13643-021-01758-7
  16. Suzuki Y. A pathway to cure chronic infection with Toxoplasma gondii through immunological intervention. Parasitol Int. 2021;81:102259. doi: 10.1016/j.parint.2020.102259
  17. Vasiliev VV, Romanova ES. Laboratory examination for toxoplasmosis: indications, Methods and results’ interpretation. Russian family doctor. 2014;18(3):4–9. (In Russ.) doi: 10.17816/RFD201434-9
  18. Catchpole A, Zabriskie BN, Bassett P, et al. Association between toxoplasma gondii Infection and type-1 diabetes mellitus: a systematic review and meta-analysis. Int J Environ Res Public Health. 2023;20(5):4436. doi: 10.3390/ijerph20054436
  19. Yin K, Xu C, Zhao G, Xie H. Epigenetic manipulation of psychiatric behavioral disorders induced by Toxoplasma gondii. Front Cell Infect Microbiol. 2022;12:803502. doi: 10.3389/fcimb.2022.803502
  20. Bassett P, Zabriskie BN, Catchpole A, Hedges D. Association between Toxoplasma gondii and systemic lupus erythematosus: A systematic review and meta-analysis. J Transl Autoimmun. 2022;5:100163. doi: 10.1016/j.jtauto.2022.100163
  21. Daher D, Shaghlil A, Sobh E, et al. Comprehensive overview of toxoplasma gondii-induced and associated diseases. Pathogens. 2021;10(11):1351. doi: 10.3390/pathogens10111351
  22. Holec-Gąsior L, Sołowińska K. IgG avidity test as a tool for discrimination between recent and distant toxoplasma gondii infection-current status of studies. Antibodies (Basel). 2022;11(3):52. doi: 10.3390/antib11030052
  23. Zhao XY, Ewald SE. The molecular biology and immune control of chronic Toxoplasma gondii infection. J Clin Invest. 2020;130(7):3370–3380. doi: 10.1172/JCI136226
  24. Álvarez García G, Davidson R, Jokelainen P, et al. Identification of oocyst-driven toxoplasma gondii infections in humans and animals through stage-specific serology-current status and future perspectives. Microorganisms. 2021;9(11):2346. doi: 10.3390/microorganisms9112346
  25. Vasiliev VV, Timchenko VN, Vasillieva IS. Ratsionalnaya terapiya toxoplazmoza. Detskie infektsii. 2004;3:42–46. (In Russ.)
  26. Lobzin YuV, Kalinina NM, Vasiliev VV, Sysoev KA. Immunomodulation by toxoplasmin in chronic toxoplasmosis treatment. Meditsinskaya immunologiya. 2000;2(3):299–304. (In Russ.)

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2023 Eco-Vector

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
 


Согласие на обработку персональных данных

 

Используя сайт https://journals.rcsi.science, я (далее – «Пользователь» или «Субъект персональных данных») даю согласие на обработку персональных данных на этом сайте (текст Согласия) и на обработку персональных данных с помощью сервиса «Яндекс.Метрика» (текст Согласия).